Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update (A54386) - R11 - Effective October 1, 2024

Date Posted: September 5, 2024

This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).

Effective Date: October 1, 2024

Summary of Article Changes:

Under ICD-10 Codes that Support Medical Necessity Group 1: Codes deleted C86.1 and C88.4. Added C83.390 and C83.398. This revision is due to the Annual ICD-10-CM Update and will become effective on 10/1/2024.

Visit the Noridian Active MolDX Billing and Coding Articles and Educational Articles webpage to view the complete listing of coverage articles and articles available in the CMS MCD.

Last Updated Sep 05 , 2024